Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
66,187,888
-
Shares change
-
-2,443,900
-
Total reported value, excl. options
-
$378,596,446
-
Value change
-
-$7,375,510
-
Put/Call ratio
-
40%
-
Number of buys
-
57
-
Number of sells
-
-45
-
Price
-
$5.72
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q4 2019
148 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q4 2019.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66,187,888 shares
of 117,273,296 outstanding shares and own 56% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (9,246,800 shares), Bain Capital Life Sciences Investors, LLC (8,452,235 shares), BlackRock Inc. (6,181,895 shares), VANGUARD GROUP INC (4,147,494 shares), Chicago Capital, LLC (3,999,740 shares), Senvest Management, LLC (3,988,889 shares), Bain Capital Public Equity Management II, LLC (3,559,547 shares), STATE STREET CORP (3,442,677 shares), RA CAPITAL MANAGEMENT, L.P. (2,365,912 shares), and UBS ASSET MANAGEMENT AMERICAS INC (1,741,106 shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.